Early detection of coPD in smoking cessation outpatient

##plugins.themes.academic_pro.article.sidebar##

Published Nov 30, 2015
Download
pdf
Vol. 93 No. 7 (2015): Issue Jul 2015

##plugins.themes.academic_pro.article.main##

Sonia Rouatbi
Sonia Mezghani
Maha Khalfallah
Mohamed Benzarti

Abstract

SUMMARY
Background: Chronic Obstructive Pulmonary Disease (COPD) is among the leading causes of chronic morbidity and mortality throughout the world. Potentially, COPD can be prevented by the early detection of COPD, which generally entails spirometry. Physicians in smoking cessation outpatient are in an ideal position to detect early-stage of COPD by the simple examination of the patient. They can also perform spirometry to confirm the diagnosis of COPD. The main objective of this study was to assess the frequency of COPD among smokers in smoking cessation outpatient. Secondary objectives were to Compare two methods for COPD screening, the questionnaire (clinical score) and the mini-electronic spirometer (Neo-6) and to assess the degree of motivation to stop smoking by the announcement of lung age to smokers.
Methods: a prospective cross-sectional study was carried out in four consultations for smoking cessation. Inclusion criteria were male patients aged over 35 years and seen in smoking cessation outpatient. A clinical score was then calculated to detect COPD. This score is based on age, BMI, the quantity of tobacco smoking and the respiratory clinical signs. By establishing this score, we could classify our smokers on consultants with likely COPD if the clinical score>16. Secondly, a measure of the breath with a portable minispirometre "neo6" was performed with quantification of the first second forced expiratory volume (FEV1), forced expiratory volume in 6 seconds (FEV6) and their ratio (FEV1/FEV6). A ratio FEV1/FEV6 less than 0.8 was in favor of an obstructive ventilator defect (DVO). In this case a total body plethysmography was indicated.

Results:The sample of the study consisted of 115 male smokers with a mean age of 48 ± 12 years old. A low socio-economic level and a low level of education were found respectively in 50.4% and 58% of smokers. Cigarette smoking is the most consumed form of tobacco. A significant clinical score predicting COPD, was found in 54 patients. The measurement of the breath through the Neo-6 found that 23 (20%) smokers had FEV1/FEV6 less than or equal to 0.7 predicting bronchial obstruction and 26 had a ratio between 0.7 and 0.8. plethysmography confirmed the diagnosis of COPD for 27 patients. So the prevalence of COPD in our sample was of 23.48%. The clinical score had a sensibility of 81.48% and a specificity of 63.64 with a negative predictive value of 91.8%. The sensitivity of the Neo 6 (70.37%) is smaller than the clinical score but the specificity is better than 95.94 % of the clinical score. Its negative predictive value was 91.3%. So when VEMS/VEM6 ratio is greater than 0.7, the probability of COPD remains very low. The announcement of the pulmonary patient age is an important parameter for the motivation to stop smoking.
Conclusion: The combination of a standardized questionnaire to the measure of breath by Neo6 can further optimize COPD screening.

##plugins.themes.academic_pro.article.details##

References

  1. Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global Burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28(3) 523-532.
  2. Organisation mondiale de la santé. Tobacco or health. A global status report. Genève : OMS 2008.
  3. Gorecka D,Bednarek M, Nowinski A, et al . Diagnosis of airway limitation combined with smoking cessation advice increases stop smoking rate. Chest 2003; 123:1916-1923
  4. Pauwels RA, Buist AS,Calverley PM, et al. Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 136:1256-1276 .
  5. Kaplan A, Rodriguez M. Early diagnosis of COPD does help ! IPCRG Opinion Sheet 5 ; International Primary Care Respiratory Group. 17 Novemmber 2009[ Accessed 22 December 2010] : Available from http : // www.theip.org/ressources:ipcrg_copd_opinion_5.pdf
  6. Sichletidis L, Papaionnou M, Spyratos D, Chloros D, Tsiotsios A, Haidich A-B et al. Comparison of different methods for COPD diagnosis in the primary care setting. Eur Respir J 2010; 36: A2142.
  7. Frith P, Crockett A, Beilby J, Marshall D, Attewell R, Ratnanessan A, Gavagna G. Simplified COPD screening : validation of the Piko-6 in primary care. Prim Care Respir J 2011; 20(2):190-198.
  8. Fagerström KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978; 3 :235-41.
  9. Sadoul P, Palu JM. Aspect clinique de la bronchite chronique. Bull Physiopath Resp 1973; 9:961-78
  10. Tabka Z, Hassayoune H, Guenard et al. Spirometric reference values in a Tunisian Population. Tunis Med 1995 ; 73 : 125-131.
  11. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R et al.: ATS/ERS Task Force: standardisation of lung function testing. Interpretative strategies for lung function tests. Eur Respir J 2005; 26:948-968.
  12. Roche N. Quality of care in chronic obstructive pulmonary disease. Rev Mal Respir 2006; 23:6S44-6S56
  13. Global Strategy for Diagnosis, Management, and Prevention of COPD Updated February 2013. Available at www.goldcopd.com
  14. James F, Morris MD and William Temple. Short Report Spirometric « Lung age » Estimation for Motivating Smoking Cassation. Preventive Medicine 1985;14:655-662.
  15. Britton M. The burden of COPD in the UK: results from the confronting COPD survey. Respir Med 2003; 97: S71-S79
  16. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020. Global Burden of Disease Study. Lancet 1997;349:1498-1504
  17. Halbert RJ, Natoli JL, Gano A, et al. Global burden of COPD: Systematic review and meta-analysis. Eur Respir J 2006;28(3):523-532.
  18. Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J . Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008;63(5):402-407.
  19. Mador MJ, Bozkanat E. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Respir Res 2001; 2: 216-224.
  20. Tashkin DP, Celli B, Senn S and al. A 4 year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease. NEJM 2008 ; 359(15) : 1543-1554.
  21. Société de Pneumologie de Langue Francaise (SPLF): Recommandations pour la prise en charge de la BPCO. Rev Mal Respir 2003 ; 20 : 294-9.
  22. Gill-Guillen V, Orozco-Beltran D, Concepcion V, Carratala Munuera et al. FUMEPOC : Early detection of chronic obstructive pulmonary disease in smokers. BMC Public Health 2011;11:413.
  23. Stang P, Lydick E , Siberman C et al. The Prevalence of COPD using Smoking Rates to Estimate Disease Frequency in the General Population. Chest 2000;117(5):3545-3595.
  24. Kohansal R, Martinez-Camblor P, Agusti A, Buist S, Mannino D, Soriano B. The natural history of chronic airflow obstruction revisited. An analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 2009 ; 180 : 3-10.
  25. Huchon GJ, Vergnenegre A, Neukirch F et al. Chronic Bronchitis among French adults: high prevalence and underdiagnosis. Eur Respir J 2002 ; 20 : 806-812.
  26. Tzanakis N, Anagnostopoulou U, Filaditaki V, Christaki P, Siafakas N: Prevalence of COPD in Greece. Chest 200 ;125:892-900..
  27. Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration 2006;73:285-295.
  28. Jimenez-Ruiz CA, Masa F, Miravitlles M, Gabriel R, Viejo JL, Villasante C, Sobradillo V: Smoking characteristics: Differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest 2001;119:1365-1370
  29. Britt-Marie Sundblad, Kjell Larsson, Lennart Nathell. Lung function testing influences the attitude toward smoking cessation. Nicotine Tob Res 2010 Jan 19;12(1):37-42
  30. Parkes G, Greenhalgh T, Griffin M, Dent R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. BMJ 2008;336:598-600.